Exclusion Criteria:~* Non-AD dementia or significant neurological disease such as Parkinson's disease, stroke,
brain tumor,multiple sclerosis, seizure disorder, focal brain lesion, or head injury with loss of
consciousness.~* Hypothyroidism, congestive heart failure (New York Heart Association Class III or IV),
significant extrapyramidal symptoms on neurological examination, serum creatinine>1.3 mg/dl, significant
arrhythmias or conduction defect abnormalities on ECG,~* Use of another beta2 adrenergic drug within the last 2
months.~* Residence in a long-term care facility.~* Evidence of any significant clinical disorder or laboratory
finding that renders the person unsuitable for receiving an investigational new drug.~* Known hypersensitivity
or prior exposure to formoterol.~* Active asthma or family history of asthma.
